PDL BioPharma offers notes

PDL BioPharma Inc. (Nasdaq: PDLI) will offer $150 million in new convertible senior notes. The stock price lost 67 cents to close at $3.05.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.